Keep Us Strong WikiLeaks logo

Currently released so far... 97115 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ETRD EAGR ETTC EAID ECON EFIN ECIN EINV ELAB EAIR ENRG EPET EWWT ECPS EIND EMIN ELTN EC ETMIN EUC EZ ET ELECTIONS ENVR EU EUN EG EINT ER ECONOMICS ES EMS ENIV EEB EN ECE ECOSOC EK ENVIRONMENT EFIS EI EWT ENGRD ECPSN EXIM EIAD ERIN ECPC EDEV ENGY ECTRD EPA ESTH ECCT EINVECON ENGR ERTD EUR EAP EWWC ELTD EL EXIMOPIC EXTERNAL ETRDEC ESCAP ECO EGAD ELNT ECONOMIC ENV ETRN EIAR EUMEM ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EREL ECOM ECONETRDEAGRJA ETCC ETRG ECONOMY EMED ETR ENERG EITC EFINOECD EURM EENG ERA EXPORT ENRD ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EGEN EBRD EVIN ETRAD ECOWAS EFTA ECONETRDBESPAR EGOVSY EPIN EID ECONENRG EDRC ESENV ETT EB ENER ELTNSNAR ECHEVARRIA ETRC EPIT EDUC ESA EFI ENRGY ESCI EE EAIDXMXAXBXFFR EETC ECIP EIAID EIVN EBEXP ESTN EING EGOV ETRA EPETEIND ELAN ETRDGK EAIDRW ETRDEINVECINPGOVCS EPEC ENVI ELN EAG EPCS EPRT EPTED ETRB EUM EAIDS EFIC EFINECONEAIDUNGAGM EAIDAR ESF EIDN ELAM EDU EV EAIDAF ECN EDA EXBS EINTECPS ENRGTRGYETRDBEXPBTIOSZ EPREL EAC EINVEFIN ETA EAGER EINDIR ECA ECLAC ELAP EITI EUCOM ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID EARG ELDIN EINVKSCA ENNP EFINECONCS EFINTS ECCP ETC EAIRASECCASCID EINN ETRP EAIDNI EFQ ECOQKPKO EGPHUM EBUD ECONEINVEFINPGOVIZ ENERGY ELB EINDETRD EMI ECONEFIN EIB EURN ETRDEINVTINTCS EIN EFIM ETIO ELAINE EMN EATO EWTR EIPR EINVETC ETTD ETDR EIQ ECONCS EPPD ENRGIZ EISL ESPINOSA ELEC EAIG ESLCO EUREM ENTG ERD EINVECONSENVCSJA EEPET EUNCH ECINECONCS ETRO ETRDECONWTOCS ECUN EFND EPECO EAIRECONRP ERGR ETRDPGOV ECPN ENRGMO EPWR EET EAIS EAGRE EDUARDO EAGRRP EAIDPHUMPRELUG EICN ECONQH EVN EGHG ELBR EINF EAIDHO EENV ETEX ERNG ED
KMDR KPAO KPKO KJUS KCRM KGHG KFRD KWMN KDEM KTFN KHIV KGIC KIDE KSCA KNNP KHUM KIPR KSUM KISL KIRF KCOR KRCM KPAL KWBG KN KS KOMC KSEP KFLU KPWR KTIA KSEO KMPI KHLS KICC KSTH KMCA KVPR KPRM KE KU KZ KFLO KSAF KTIP KTEX KBCT KOCI KOLY KOR KAWC KACT KUNR KTDB KSTC KLIG KSKN KNN KCFE KCIP KGHA KHDP KPOW KUNC KDRL KV KPREL KCRS KPOL KRVC KRIM KGIT KWIR KT KIRC KOMO KRFD KUWAIT KG KFIN KSCI KTFIN KFTN KGOV KPRV KSAC KGIV KCRIM KPIR KSOC KBIO KW KGLB KMWN KPO KFSC KSEAO KSTCPL KSI KPRP KREC KFPC KUNH KCSA KMRS KNDP KR KICCPUR KPPAO KCSY KTBT KCIS KNEP KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNNB KGCC KINR KPOP KMFO KENV KNAR KVIR KDRG KDMR KFCE KNAO KDEN KGCN KICA KIMMITT KMCC KLFU KMSG KSEC KUM KCUL KMNP KSMT KCOM KOMCSG KSPR KPMI KRAD KIND KCRP KAUST KWAWC KTER KCHG KRDP KPAS KITA KTSC KPAOPREL KWGB KIRP KJUST KMIG KLAB KTFR KSEI KSTT KAPO KSTS KLSO KWNN KPOA KHSA KNPP KPAONZ KBTS KWWW KY KJRE KPAOKMDRKE KCRCM KSCS KWMNCI KESO KWUN KPLS KIIP KEDEM KPAOY KRIF KGICKS KREF KTRD KFRDSOCIRO KTAO KJU KWMNPHUMPRELKPAOZW KEN KO KNEI KEMR KKIV KEAI KWAC KRCIM KWCI KFIU KWIC KCORR KOMS KNNO KPAI KBWG KTTB KTBD KTIALG KILS KFEM KTDM KESS KNUC KPA KOMCCO KCEM KRCS KWBGSY KNPPIS KNNPMNUC KWN KERG KLTN KALM KCCP KSUMPHUM KREL KGH KLIP KTLA KAWK KWMM KVRP KVRC KAID KSLG KDEMK KX KIF KNPR KCFC KFTFN KTFM KPDD KCERS KMOC KDEMAF KMEPI KEMS KDRM KEPREL KBTR KEDU KNP KIRL KNNR KMPT KISLPINR KTPN KA KJUSTH KPIN KDEV KTDD KAKA KFRP KWNM KTSD KINL KJUSKUNR KWWMN KECF KWBC KPRO KVBL KOM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KEDM KFLD KLPM KRGY KNNF KICR KIFR KM KWMNCS KAWS KLAP KPAK KDDG KCGC KID KNSD KMPF KPFO KDP KCMR KRMS KNPT KNNNP KTIAPARM KDTB KNUP KPGOV KNAP KNNC KUK KSRE KREISLER KIVP KQ KTIAEUN KPALAOIS KRM KISLAO KWM KFLOA
PHUM PINR PTER PGOV PREL PREF PL PM PHSA PE PARM PINS PK PUNE PO PALESTINIAN PU PBTS PROP PTBS POL POLI PA PGOVZI POLMIL POLITICAL PARTIES POLM PD POLITICS POLICY PAS PMIL PINT PNAT PV PKO PPOL PERSONS PING PBIO PH PETR PARMS PRES PCON PETERS PRELBR PT PLAB PP PAK PDEM PKPA PSOCI PF PLO PTERM PJUS PSOE PELOSI PROPERTY PGOVPREL PARP PRL PNIR PHUMKPAL PG PREZ PGIC PBOV PAO PKK PROV PHSAK PHUMPREL PROTECTION PGOVBL PSI PRELPK PGOVENRG PUM PRELKPKO PATTY PSOC PRIVATIZATION PRELSP PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PREC PAIGH PROG PSHA PARK PETER POG PHUS PPREL PS PTERPREL PRELPGOV POV PKPO PGOVECON POUS PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PWBG PMAR PREM PAR PNR PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PARMIR PGOVGM PHUH PARTM PN PRE PTE PY POLUN PPEL PDOV PGOVSOCI PIRF PGOVPM PBST PRELEVU PGOR PBTSRU PRM PRELKPAOIZ PGVO PERL PGOC PAGR PMIN PHUMR PVIP PPD PGV PRAM PINL PKPAL PTERE PGOF PINO PHAS PODC PRHUM PHUMA PREO PPA PEPFAR PGO PRGOV PAC PRESL PORG PKFK PEPR PRELP PREFA PNG PGOVPHUMKPAO PRELECON PINOCHET PFOR PGOVLO PHUMBA PRELC PREK PHUME PHJM POLINT PGOVPZ PGOVKCRM PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PRELSW PAHO PEDRO PRELA PASS PPAO PGPV PNUM PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PRFE POGOV PEL PBT PAMQ PINF PSEPC POSTS PHUMPGOV PVOV PHSAPREL PROLIFERATION PENA PRELTBIOBA PIN PRELL PGOVPTER PHAM PHYTRP PTEL PTERPGOV PHARM PROTESTS PRELAF PKBL PRELKPAO PKNP PARMP PHUML PFOV PERM PUOS PRELGOV PHUMPTER PARAGRAPH PERURENA PBTSEWWT PCI PETROL PINSO PINSCE PQL PEREZ PBS

Browse by classification

Community resources

courage is contagious

Viewing cable 08GENEVA275, U.S. GOVERNMENT OFFICIALS MEET WITH INDONESIAN

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08GENEVA275.
Reference ID Created Released Classification Origin
08GENEVA275 2008-04-11 06:55 2011-08-25 00:00 UNCLASSIFIED//FOR OFFICIAL USE ONLY US Mission Geneva
VZCZCXYZ0000
PP RUEHWEB

DE RUEHGV #0275/01 1020655
ZNR UUUUU ZZH
P 110655Z APR 08
FM USMISSION GENEVA
TO RUEHC/SECSTATE WASHDC PRIORITY 6322
INFO RUEHBY/AMEMBASSY CANBERRA PRIORITY 6421
RUEHJA/AMEMBASSY JAKARTA PRIORITY 2225
RUEHPH/CDC ATLANTA GA USA PRIORITY
RUCPDOC/DEPT OF COMMERCE WASHINGTON DC PRIORITY
RUEAUSA/DEPT OF HHS WASHINGTON DC PRIORITY
RHEHNSC/NATIONAL SECURITY COUNCIL WASHINGTON DC PRIORITY
RUCNDT/USMISSION USUN NEW YORK PRIORITY 2709
UNCLAS GENEVA 000275 
 
SIPDIS 
 
SENSITIVE 
SIPDIS 
 
DEPT FOR G/AIAG, IO/T, OES 
PASS TO HSC 
 
E.O. 12958: N/A 
TAGS: KFLU TBIO EAID WHO
SUBJECT: U.S. GOVERNMENT OFFICIALS MEET WITH INDONESIAN 
MINISTER OF HEALTH 
 
REF: GENEVA 2507 (07) 
 
1.  Summary.  Ambassador John Lange, Special Representative 
of the Secretary of State for Avian and Pandemic Influenza, 
and Dr. William Steiger, Special Assistant for International 
Affairs to the U.S. Secretary of Health and Human Services, 
met with Indonesian Minister of Health Siti Fadilah Supari, 
at her request, in Geneva, on April 2, 2008.  They discussed 
issues related to the World Health Organization (WHO) 
intergovernmental process on pandemic-influenza preparedness, 
particularly the sharing of influenza viruses and access to 
vaccines and other benefits.  The conversation covered 
possible material-transfer agreements, traceability 
mechanisms, a new name for the WHO Global Influenza 
Surveillance Network (GISN), and access to benefits that 
might result from the sharing of influenza viruses.  Although 
the discussion covered familiar ground, Minister Supari 
introduced a specific idea that monetary benefits should flow 
directly to the countries that provide virus samples to the 
WHO network, based on a percentage of sales of commercially 
viable vaccines produced from those samples, a mechanism 
commonly known as a royalty.  The meeting ended 
inconclusively, although the two sides did appear to share 
common ground on several aspects of the debate around 
sample-sharing. End Summary. 
 
2.  Ambassador John Lange, Special Representative of the 
Secretary of State on Avian and Pandemic Influenza, and Dr. 
 
SIPDIS 
William Steiger, Special Assistant for International Affairs 
to the U.S. Secretary of Health and Human Services (HHS), met 
with Indonesian Minister of Health Siti Fadilah Supari, at 
her request, in Geneva, on April 2, 2008.  David Hohman, 
Health Attache at U.S. Mission Geneva, accompanied Steiger 
and Lange.  Dr. Widjaja Lukito, Minister Supari's adviser on 
influenza issues; Dr. Indriyono Tantoro, an adviser to the 
Minister; and Cecep Herawan of the Indonesian Mission in 
Geneva, accompanied Minister Supari. 
 
3.  Steiger, who had earlier met with Minister Supari in 
Geneva on January 22, 2008, on the margins of the WHO 
Executive Board, opened by expressing appreciation both for 
the suggestion of the meeting and for the leadership Minister 
Supari has demonstrated on the issue of injecting more 
transparency, fairness and clarity in the system for sharing 
influenza viruses.  Lange expressed appreciation for 
Indonesian participation in the recent Sydney discussions, 
and noted that the WHO negotiations later in the week would 
be in a multilateral context.  The Minister thanked the 
United States for agreeing to the meeting, and asked Dr. 
Widjaja to discuss four issues:  material-transfer 
agreements, traceability mechanisms, a new name for the WHO 
global influenza surveillance network (GISN), and access to 
benefits that might result from the sharing of influenza 
viruses. 
 
4.  Dr. Widjaja noted the progress he believed the United 
States and Indonesia made in informal discussions facilitated 
by Australia on these issues, held from March 17-19, in 
Sydney.  He then discussed the improvements Indonesia sees as 
needed to the traceability mechanism for virus samples the 
WHO secretariat had developed in response to a request from 
the WHO intergovernmental meeting (IGM) on pandemic-influenza 
preparedness, which last met in November 2007.  Widjaja 
stressed countries needed a more user-friendly mechanism that 
provided data in real-time.  He cited the Global Initiative 
on Sharing Avian Influenza Data (GISAID) as a possible model, 
and indicated he had learned more about this system at the 
Swiss Institute of Bioinformatics on his last visit to 
Geneva, in January 2008.  He also suggested an effective, 
robust traceability mechanism might eventually make 
unnecessary the advisory, or oversight, group called for by 
the November IGM. 
 
5.  Turning to the subject of material-transfer agreements 
(MTAs), Widjaja said the IGM discussion was "stuck" on the 
issue of transferring seed viruses to commercial vaccine 
manufacturers, which would require prior, informed consent of 
the originating country (a familiar Indonesian priority).  He 
agreed that countries could send viruses to WHO collaborating 
centers for risk-assessment purposes, and acknowledged that a 
standard, universal MTA was a possibility, but the elements 
 
of such an agreement needed further work.  The Minister 
intervened to stress that Indonesian law required that any 
biological sample shipped out of the country carry an MTA. 
 
6.  In concluding, Widjaja proposed to re-name the current 
Global Influenza Surveillance Network (GISN) as the "WHO 
Influenza Network," or "WIN," and said the terms of reference 
(TORs) for each element of the "WIN" (especially the WHO 
collaborating centers on influenza, the H5 reference 
laboratories, and so-called "essential regulatory 
laboratories," a category discussed at the Singapore 
Interdisciplinary Meeting and at the IGM in November 2007) 
needed revision. 
 
7.  Responding to Widjaja's points, Steiger agreed replacing 
"GISN" with "WIN" would likely find general acceptance, and 
stressed every element of the network required TORs, 
including the National Influenza Centers (NICS), which 
Widjaja had not mentioned.  Steiger emphasized that the TORs 
must provide clear guidance for everyone involved in the 
network, and suggested the IGM should consider supporting the 
establishment of new WHO collaborating centers on influenza, 
particularly in developing countries, provided the 
institutions could meet and maintain the rigorous standards 
the WHO Secretariat sets for such designations. 
 
8.  Turning to the governance of the WHO network, Steiger 
suggested an advisory group might be necessary, especially in 
the short term, while member States and the WHO Secretariat 
improved the traceability mechanism.  He agreed the tracking 
system had to be simple, fast, internet-based (with password 
protection), and user-friendly.  He said the U.S. Government 
did not know whether GISAID was the right system, but 
stressed U.S. technical agencies were willing to look at a 
number of candidates. In any case, he said the scientists 
within the WHO influenza network, especially from affected 
countries, should determine their needs, and test the GISAID 
system and other models.  Steiger said Ambassador Lange would 
announce at the upcoming meeting of the IGM Working Group 
that the United States, through HHS, would reprogram $500,000 
of a cooperative agreement already awarded to the WHO 
Secretariat to support work on improving the traceability 
 
SIPDIS 
mechanism, including through the hiring of a dedicated 
project manager. 
 
9.  Discussing the sharing of possible benefits, Steiger 
stressed that well-defined benefits should be available for 
all countries in need, not just those who had cases of the 
H5N1 virus today.  He said the WHO Secretariat had more work 
to do on developing a vaccine stockpile, which now consisted 
only of a pledge from GlaxoSmithKline of 50 million doses of 
an as-yet-unlicensed vaccine.  He also pointed to the 
technical assistance provided by WHO member States and the 
WHO Secretariat on containment measures; training; 
non-pharmaceutical interventions, such as 
community-mitigation strategies; and technology transfer to 
improve the production of influenza vaccine in developing 
countries.  He also said vaccine manufacturers have a 
voluntary responsibility to contribute to WHO-managed 
stockpiles, and to support safe vaccine-production capacity 
in developing countries, one of Secretary Leavitt's strategic 
goals. 
 
10.    Minister Supari, noting Steiger had touched on a 
sensitive issue, repeated her concern that vaccine 
manufacturers receive free material to develop vaccines but 
source countries do not benefit.  The Minister then 
introduced a specific idea - she said source countries should 
receive a percentage of the sales of commercially viable 
vaccines developed from their viruses.  When Steiger asked if 
she was talking about royalties, the minister said, "No, I do 
not want to touch (intellectual property)."  She stressed, 
however, that the material provided by source countries had 
value, and she wanted the world community to recognize that 
value.  (Comment:  although the royalty idea is not new, we 
have not heard it for at least a year.  When Ambassador Lange 
later asked Widjaja why he had not raised this at the Sydney 
meeting, Widjaja said he only had permission to discuss 
non-monetary benefits, and it was the Minister's purview to 
discuss monetary benefits.  He also said he would not raise 
monetary benefits in the IGM Working Group meeting. In 
 
previous discussions with U.S. Government officials, 
including with Steiger in January 2008 and with HHS Secretary 
Leavitt at the World Health Assembly in 2007, Minister Supari 
denied she was seeking royalties. End comment.) 
 
11.    Returning to the subject of possible material-transfer 
agreements, Steiger stressed there must be one, universal 
agreement, negotiated once, applicable to all, linked to the 
traceability mechanism, web-based, and that would track 
viruses in and out of the WHO system.  He agreed that MTAs, 
or standard terms and conditions, should indicate the 
provenance of viruses, and include provisions that would 
recognize the contributions of scientists in source countries. 
 
12.    Minister Supari then asked when Steiger thought 
Indonesia would have its own WHO collaborating center on 
influenza.  Saying he could not answer that question, Steiger 
noted the Eijkman Institute, with its laboratory certified at 
biosafety level three, had the potential over time to earn 
this designation from the WHO Secretariat. 
 
13.  Noting the Minister had asked him at their meeting in 
January why vaccine-manufacturer Baxter was not fulfilling 
the terms of its agreement with the Indonesian government 
related to the development and testing of an H5N1 vaccine, 
Steiger said he had learned the sticking point for the 
company related to indemnification.  He urged the Minister to 
have her lawyers explore the indemnification proposal from 
Baxter. 
 
14.  In concluding the meeting, Steiger told Minister Supari 
that HHS Secretary Leavitt very much looked forward to his 
visit to Indonesia later in the month, and to meeting with 
President Yudhoyono, Coordinating Minister Bakrie, and her. 
 
 
 
STORELLA